{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T13:02:33Z","timestamp":1775048553719,"version":"3.50.1"},"reference-count":145,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>The high mortality of specific groups from COVID-19 highlights the importance of host\u2013viral interactions and the potential benefits from enhancing host defenses. SARS-CoV-2 requires angiotensin-converting enzyme (ACE) 2 as a receptor for cell entry and infection. Although both ACE inhibitors and spironolactone can upregulate tissue ACE2, there are important points of discrimination between these approaches. The virus requires proteolytic processing of its spike protein by transmembrane protease receptor serine type 2 (TMPRSS2) to enable binding to cellular ACE2. Because TMPRSS2 contains an androgen promoter, it may be downregulated by the antiandrogenic actions of spironolactone. Furin and plasmin also process the spike protein. They are inhibited by protease nexin 1 or serpin E2 (PN1) that is upregulated by angiotensin II but downregulated by aldosterone. Therefore, spironolactone should selectively downregulate furin and plasmin. Furin also promotes pulmonary edema, whereas plasmin promotes hemovascular dysfunction. Thus, a downregulation of furin and plasmin by PN1 could be a further benefit of MRAs beyond their well-established organ protection. We review the evidence that spironolactone may be the preferred RASSi to increase PN1 and decrease TMPRSS2, furin, and plasmin activities and thereby reduce viral cell binding, entry, infectivity, and bad outcomes. This hypothesis requires direct investigation.<\/jats:p>","DOI":"10.1097\/fjc.0000000000000960","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T06:00:09Z","timestamp":1607148009000},"page":"323-331","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Is Spironolactone the Preferred Renin\u2013Angiotensin\u2013Aldosterone Inhibitor for Protection Against COVID-19?"],"prefix":"10.1097","volume":"77","author":[{"given":"Christopher S.","family":"Wilcox","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension Center, Georgetown University, Washington, DC; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Michigan, Ann Arbor, MI."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamacardio.2020.1329","article-title":"The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science","volume":"5","author":"AlGhatrif","year":"2020","journal-title":"JAMA Cardiol."},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/CS20200363","article-title":"Ace2 the janus-faced protein\u2014from cardiovascular protection to severe acute respiratory syndrome-coronavirus and covid-19","volume":"134","author":"Touyz","year":"2020","journal-title":"Clin Sci."},{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for covid-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med."},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1093\/eurheartj\/ehaa373","article-title":"Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors","volume":"41","author":"Sama","year":"2020","journal-title":"Eur Heart J."},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the sars coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature."},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"Sars-cov-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell."},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: sars-cov-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ace2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ Res."},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-angiotensin system blockers and the covid-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension."},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"e57278","DOI":"10.7554\/eLife.57278","article-title":"Potential harmful effects of discontinuing ace-inhibitors and arbs in covid-19 patients","volume":"9","author":"Rossi","year":"2020","journal-title":"eLife."},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with covid-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res."},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"New Engl J Med."},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary angiotensin-converting enzyme 2 (ace2) and inflammatory lung disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock."},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/HYPERTENSIONAHA.110.164244","article-title":"Prevention of angiotensin ii-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2","volume":"57","author":"Zhong","year":"2011","journal-title":"Hypertension."},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through receptor mas mediates endothelial nitric oxide synthase activation via akt-dependent pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension."},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCRESAHA.116.310509","article-title":"Clinical relevance and role of neuronal at(1) receptors in adam17-mediated ace2 shedding in neurogenic hypertension","volume":"121","author":"Xu","year":"2017","journal-title":"Circ Res."},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"e20201000","DOI":"10.1084\/jem.20201000","article-title":"The renin-angiotensin system: an integrated view of lung disease and coagulopathy in covid-19 and therapeutic implications","volume":"217","author":"Diamond","year":"2020","journal-title":"J Exp Med."},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature."},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ace2) in sars coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med."},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of sars-cov-2 infections in engineered human tissues using clinical-grade soluble human ace2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41569-020-0368-x","article-title":"Interaction between raas inhibitors and ace2 in the context of covid-19","volume":"17","author":"Mourad","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"Covid-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"R23-20250802","first-page":"450","article-title":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for sars coronavirus infection","volume":"57","author":"Yang","year":"2007","journal-title":"Comp Med."},{"key":"R24-20250802","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ace2) as a sars-cov-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"e93719","DOI":"10.1371\/journal.pone.0093719","article-title":"New perspectives in the renin-angiotensin-aldosterone system (raas) iii: endogenous inhibition of angiotensin converting enzyme (ace) provides protection against cardiovascular diseases","volume":"9","author":"Fagyas","year":"2014","journal-title":"PLoS One."},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)."},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"e2011122","DOI":"10.1001\/jamanetworkopen.2020.11122","article-title":"Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China","volume":"3","author":"Chen","year":"2020","journal-title":"JAMA Netw Open."},{"key":"R28-20250802","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease tmprss2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J Virol."},{"key":"R29-20250802","first-page":"1","article-title":"A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin","volume":"0","author":"Hasan","year":"2020","journal-title":"J Biomol Struct Dyn."},{"key":"R30-20250802","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the sars-cov-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"R31-20250802","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of sars-cov-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol Cel."},{"key":"R32-20250802","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","article-title":"Elevated plasmin(ogen) as a common risk factor for covid-19 susceptibility","volume":"100","author":"Ji","year":"2020","journal-title":"Physiol Rev."},{"key":"R33-20250802","doi-asserted-by":"crossref","first-page":"e7870","DOI":"10.1371\/journal.pone.0007870","article-title":"Cleavage of the sars coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro","volume":"4","author":"Kam","year":"2009","journal-title":"PLoS One."},{"key":"R34-20250802","doi-asserted-by":"crossref","first-page":"110112","DOI":"10.1016\/j.mehy.2020.110112","article-title":"Spironolactone may provide protection from sars-cov-2: targeting androgens, angiotensin converting enzyme 2 (ace2), and renin-angiotensin-aldosterone system (raas)","volume":"143","author":"Cadegiani","year":"2020","journal-title":"Med Hypotheses."},{"key":"R35-20250802","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5152\/TJAR.2020.569","article-title":"Use of spironolactone in sars-cov-2 ards patients","volume":"48","author":"Dumanli","year":"2020","journal-title":"Turkish J Anaesthesiol Reanimation."},{"key":"R36-20250802","first-page":"Cd008996","article-title":"Eplerenone for hypertension","volume":"2","author":"Tam","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"key":"R37-20250802","doi-asserted-by":"crossref","first-page":"e0254","DOI":"10.1097\/MD.0000000000010254","article-title":"The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure: a systematic review and meta-analysis","volume":"97","author":"Pei","year":"2018","journal-title":"Medicine."},{"key":"R38-20250802","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/HYPERTENSIONAHA.120.15199","article-title":"Mineralocorticoid receptor antagonists for hypertension management in advanced chronic kidney disease: block-ckd trial","volume":"76","author":"Bakris","year":"2020","journal-title":"Hypertension."},{"key":"R39-20250802","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ace2\/angiotensin-(1-7)\/mas axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev."},{"key":"R40-20250802","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2020.8707","article-title":"Nasal gene expression of angiotensin-converting enzyme 2 in children and adults","volume":"323","author":"Bunyavanich","year":"2020","journal-title":"JAMA."},{"key":"R41-20250802","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1021\/acschemneuro.0c00210","article-title":"Expression of the sars-cov-2 entry proteins, ace2 and tmprss2, in cells of the olfactory epithelium: identification of cell types and trends with age","volume":"11","author":"Bilinska","year":"2020","journal-title":"ACS Chem Neurosci."},{"key":"R42-20250802","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ace2 protein, the functional receptor for sars coronavirus. A first step in understanding sars pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol."},{"key":"R43-20250802","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"Sars-cov-2 receptor ace2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell."},{"key":"R44-20250802","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/fcp.12318","article-title":"Angiotensin-converting enzyme 2-angiotensin 1-7\/1-9 system: novel promising targets for heart failure treatment","volume":"32","author":"Kittana","year":"2018","journal-title":"Fundam Clin Pharmacol."},{"key":"R45-20250802","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","article-title":"The anti-inflammatory potential of ace2\/angiotensin-(1-7)\/mas receptor axis: evidence from basic and clinical research","volume":"18","author":"Rodrigues Prestes","year":"2017","journal-title":"Curr Drug Targets."},{"key":"R46-20250802","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin Sci."},{"key":"R47-20250802","article-title":"Cardiovascular disease, drug therapy, and mortality in covid-19","volume":"382","author":"Mehra","year":"2020","journal-title":"New Engl J Med."},{"key":"R48-20250802","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/HYPERTENSIONAHA.120.15263","article-title":"Evidence that renin-angiotensin system inhibitors should not be discontinued due to the covid-19 pandemic","volume":"76","author":"Carey","year":"2020","journal-title":"Hypertension."},{"key":"R49-20250802","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"New Engl J Med."},{"key":"R50-20250802","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1113\/expphysiol.2007.041855","article-title":"Differential regulation of renal angiotensin-converting enzyme (ace) and ace2 during ace inhibition and dietary sodium restriction in healthy rats","volume":"93","author":"Hamming","year":"2008","journal-title":"Exp Physiol."},{"key":"R51-20250802","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin ii receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation."},{"key":"R52-20250802","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension."},{"key":"R53-20250802","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions","volume":"123","author":"Burchill","year":"2012","journal-title":"Clin Sci."},{"key":"R54-20250802","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","article-title":"Human intestine luminal ace2 and amino acid transporter expression increased by ace-inhibitors","volume":"47","author":"Vuille-dit-Bille","year":"2015","journal-title":"Amino Acids."},{"key":"R55-20250802","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin ii receptor blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am J Hypertens."},{"key":"R56-20250802","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/00004872-200410000-00020","article-title":"Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ace2) in angiotensin peptide metabolism in the human coronary circulation","volume":"22","author":"Campbell","year":"2004","journal-title":"J Hypertens."},{"key":"R57-20250802","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00004872-199606000-00017","article-title":"Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension","volume":"14","author":"Luque","year":"1996","journal-title":"J Hypertens."},{"key":"R58-20250802","first-page":"1280","article-title":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling","volume":"19","author":"Walters","year":"2017","journal-title":"Eur Soc Cardiol."},{"key":"R59-20250802","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcmg.2019.09.005","article-title":"Plasma ace2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis","volume":"13","author":"Ramchand","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"R60-20250802","doi-asserted-by":"crossref","first-page":"e0198144","DOI":"10.1371\/journal.pone.0198144","article-title":"Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease","volume":"13","author":"Ramchand","year":"2018","journal-title":"PLoS One."},{"key":"R61-20250802","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-2-19","article-title":"Ace2 gene expression is up-regulated in the human failing heart","volume":"2","author":"Goulter","year":"2004","journal-title":"BMC Med."},{"key":"R62-20250802","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1253\/circj.72.1346","article-title":"Aldosterone, but not angiotensin ii, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes","volume":"72","author":"Yamamuro","year":"2008","journal-title":"Circ J."},{"key":"R63-20250802","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","article-title":"Angiotensin at1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis","volume":"33","author":"Robert","year":"1999","journal-title":"Hypertension."},{"key":"R64-20250802","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.bbamcr.2011.07.010","article-title":"Aldosterone increases vegf-a production in human neutrophils through pi3k, erk1\/2 and p38 pathways","volume":"1813","author":"Walczak","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"R65-20250802","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10157-010-0373-1","article-title":"Aldosterone-induced kidney injury is mediated by nf\u03bab activation","volume":"15","author":"Fukuda","year":"2011","journal-title":"Clin Exp Nephrol."},{"key":"R66-20250802","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.amjhyper.2007.05.008","article-title":"Effects of aldosterone and angiotensin ii receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in dahl salt-sensitive hypertensive rats","volume":"20","author":"Takeda","year":"2007","journal-title":"Am J Hypertens."},{"key":"R67-20250802","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbrc.2005.12.194","article-title":"Aldosterone-induced abnormal regulation of enac and sgk1 in dahl salt-sensitive rat","volume":"341","author":"Aoi","year":"2006","journal-title":"Biochem Biophysical Res Commun."},{"key":"R68-20250802","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.CIR.104.2.137","article-title":"Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes","volume":"104","author":"Harada","year":"2001","journal-title":"Circulation."},{"key":"R69-20250802","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.RES.0000187500.24964.7A","article-title":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients","volume":"97","author":"Keidar","year":"2005","journal-title":"Circ Res."},{"key":"R70-20250802","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1085\/jgp.20028598","article-title":"Synergistic activation of enac by three membrane-bound channel-activating serine proteases (mcap1, mcap2, and mcap3) and serum- and glucocorticoid-regulated kinase (sgk1) in xenopus oocytes","volume":"120","author":"Vuagniaux","year":"2002","journal-title":"J Gen Physiol."},{"key":"R71-20250802","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00330.2011","article-title":"Tmprss4-dependent activation of the epithelial sodium channel requires cleavage of the \u03b3-subunit distal to the furin cleavage site","volume":"302","author":"Passero","year":"2012","journal-title":"Am J Physiol Ren Physiol."},{"key":"R72-20250802","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1515\/hsz-2012-0155","article-title":"Tmprss4 is a type ii transmembrane serine protease involved in cancer and viral infections","volume":"393","author":"Ohler","year":"2012","journal-title":"Biol Chem."},{"key":"R73-20250802","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"R74-20250802","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/path.2330","article-title":"The androgen-regulated type ii serine protease tmprss2 is differentially expressed and mislocalized in prostate adenocarcinoma","volume":"215","author":"Lucas","year":"2008","journal-title":"J Pathol."},{"key":"R75-20250802","first-page":"10087","article-title":"ace2 and tmprss2 variants and expression as candidates to sex and country differences in covid-19 severity in Italy","volume":"12","author":"Asselta","year":"2020","journal-title":"medRxiv."},{"key":"R77-20250802","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"Tmprss2 and adam17 cleave ace2 differentially and only proteolysis by tmprss2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J Virol."},{"key":"R78-20250802","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that tmprss2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J Virol."},{"key":"R79-20250802","doi-asserted-by":"crossref","first-page":"e1003774","DOI":"10.1371\/journal.ppat.1003774","article-title":"Tmprss2 is essential for influenza h1n1 virus pathogenesis in mice","volume":"9","author":"Hatesuer","year":"2013","journal-title":"PLoS Pathog."},{"key":"R80-20250802","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/JVI.03799-13","article-title":"Tmprss2 is a host factor that is essential for pneumotropism and pathogenicity of h7n9 influenza a virus in mice","volume":"88","author":"Tarnow","year":"2014","journal-title":"J Virol."},{"key":"R81-20250802","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/JVI.00128-13","article-title":"The spike protein of the emerging betacoronavirus emc uses a novel coronavirus receptor for entry, can be activated by tmprss2, and is targeted by neutralizing antibodies","volume":"87","author":"Gierer","year":"2013","journal-title":"J Virol."},{"key":"R83-20250802","first-page":"e105114","article-title":"Sars-cov-2 receptor ace2 and tmprss2 are primarily expressed in bronchial transient secretory cells","author":"Lukassen","year":"2020","journal-title":"EMBO J."},{"key":"R84-20250802","first-page":"E011","article-title":"Expression analysis of 2019-ncov related ace2 and tmprss2 in eye tissues [in Chinese]","volume":"56","author":"Zhang","year":"2020","journal-title":"Chin J Ophthalmol."},{"key":"R85-20250802","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ibd\/izaa085","article-title":"Expression of sars-cov-2 entry molecules ace2 and tmprss2 in the gut of patients with ibd","volume":"26","author":"Burgue\u00f1o","year":"2020","journal-title":"Inflamm Bowel Dis."},{"key":"R86-20250802","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/sgtp.28846","article-title":"Involvement of rho gtpases and their regulators in the pathogenesis of hypertension","volume":"5","author":"Loirand","year":"2014","journal-title":"Small GTPases."},{"key":"R87-20250802","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/j.1742-4658.2007.05756.x","article-title":"Crystal structure of the catalytic domain of desc1, a new member of the type ii transmembrane serine proteinase family","volume":"274","author":"Kyrieleis","year":"2007","journal-title":"FEBS J."},{"key":"R88-20250802","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1128\/AAC.01043-16","article-title":"Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay","volume":"60","author":"Yamamoto","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"R89-20250802","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1182\/blood.2019000281","article-title":"Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia","volume":"134","author":"Aymonnier","year":"2019","journal-title":"Blood."},{"key":"R90-20250802","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-physiol-021317-121143","article-title":"Epithelial na(+) channel regulation by extracellular and intracellular factors","volume":"80","author":"Kleyman","year":"2018","journal-title":"Annu Rev Physiol."},{"key":"R91-20250802","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MNH.0000000000000479","article-title":"New insights regarding epithelial na+ channel regulation and its role in the kidney, immune system and vasculature","volume":"28","author":"Mutchler","year":"2019","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"R92-20250802","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/bph.13533","article-title":"The function and regulation of acid-sensing ion channels (asics) and the epithelial na(+) channel (enac): iuphar review 19","volume":"173","author":"Boscardin","year":"2016","journal-title":"Br J Pharmacol."},{"key":"R93-20250802","doi-asserted-by":"crossref","first-page":"18111","DOI":"10.1074\/jbc.C400080200","article-title":"Epithelial sodium channels are activated by furin-dependent proteolysis","volume":"279","author":"Hughey","year":"2004","journal-title":"J Biol Chem."},{"key":"R94-20250802","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00370222","article-title":"Regulation of na+ channels in frog lung epithelium: a target tissue for aldosterone action","volume":"416","author":"Fischer","year":"1990","journal-title":"Pfl\u00fcgers Archiv."},{"key":"R95-20250802","doi-asserted-by":"crossref","first-page":"27942","DOI":"10.1074\/jbc.M606449200","article-title":"Airway surface liquid volume regulates enac by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis","volume":"281","author":"Myerburg","year":"2006","journal-title":"J Biol Chem."},{"key":"R96-20250802","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/eurheartj\/ehi023","article-title":"Spironolactone improves lung diffusion in chronic heart failure","volume":"26","author":"Agostoni","year":"2005","journal-title":"Eur Heart J."},{"key":"R97-20250802","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10157-010-0299-7","article-title":"Regulation of renal sodium handling through the interaction between serine proteases and serine protease inhibitors","volume":"14","author":"Kitamura","year":"2010","journal-title":"Clin Exp Nephrol."},{"key":"R98-20250802","first-page":"179","article-title":"Amiloride sensitive sodium channels (enac) and their regulation by proteases [in Spanish]","volume":"71","author":"Galizia","year":"2011","journal-title":"Medicina."},{"key":"R99-20250802","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/HJH.0b013e328317a762","article-title":"Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension","volume":"27","author":"Maekawa","year":"2009","journal-title":"J Hypertens."},{"key":"R100-20250802","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1124\/jpet.108.148155","article-title":"Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease","volume":"329","author":"Coote","year":"2009","journal-title":"J Pharmacol Exp Ther."},{"key":"R101-20250802","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1002\/term.2240","article-title":"Proprotein convertase inhibition promotes ciliated cell differentiation - a potential mechanism for the inhibition of notch1 signalling by decanoyl-rvkr-chloromethylketone","volume":"11","author":"Lee","year":"2017","journal-title":"J Tissue Eng regenerative Med."},{"key":"R102-20250802","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/jmm.0.000565","article-title":"A review of candidate therapies for middle east respiratory syndrome from a molecular perspective","volume":"66","author":"Rabaan","year":"2017","journal-title":"J Med Microbiol."},{"key":"R103-20250802","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00395-020-0791-5","article-title":"Covid-19 in the heart and the lungs: could we \u201cnotch\u201d the inflammatory storm?","volume":"115","author":"Rizzo","year":"2020","journal-title":"Basic Res Cardiol."},{"key":"R104-20250802","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1620\/tjem.239.185","article-title":"Water deprivation increases (pro)renin receptor levels in the kidney and decreases plasma concentrations of soluble (pro)renin receptor","volume":"239","author":"Tamura","year":"2016","journal-title":"Tohoku J Exp Med."},{"key":"R105-20250802","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with covid-19 in wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"R106-20250802","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-09-735720","article-title":"Plasmin: a driver of hemovascular dysfunction","volume":"128","author":"Cap","year":"2016","journal-title":"Blood."},{"key":"R107-20250802","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.2008040364","article-title":"Plasmin in nephrotic urine activates the epithelial sodium channel","volume":"20","author":"Svenningsen","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"R108-20250802","doi-asserted-by":"crossref","first-page":"E305","DOI":"10.1152\/ajpendo.00512.2007","article-title":"Aldosterone, but not angiotensin ii, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats","volume":"295","author":"Chun","year":"2008","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"R109-20250802","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1210\/jc.2003-030374","article-title":"Effect of combined at1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1","volume":"88","author":"Sawathiparnich","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"R110-20250802","doi-asserted-by":"crossref","first-page":"e74602","DOI":"10.1371\/journal.pone.0074602","article-title":"Involvement of the serine protease inhibitor, serpine2, and the urokinase plasminogen activator in cumulus expansion and oocyte maturation","volume":"8","author":"Lu","year":"2013","journal-title":"PLoS One."},{"key":"R111-20250802","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/ATVBAHA.113.301494","article-title":"Endothelial protease nexin-1 is a novel regulator of a disintegrin and metalloproteinase 17 maturation and endothelial protein c receptor shedding via furin inhibition","volume":"33","author":"Boulaftali","year":"2013","journal-title":"Arteriosclerosis Thromb Vasc Biol."},{"key":"R112-20250802","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jnr.490420414","article-title":"Regulation of protease nexin-1 and angiotensin ii receptor subtype 1 expression: inverse relationship in experimental models of nerve injury","volume":"42","author":"Bleuel","year":"1995","journal-title":"J Neurosci Res."},{"key":"R113-20250802","doi-asserted-by":"crossref","first-page":"37635","DOI":"10.1038\/srep37635","article-title":"Overexpression of serpine2\/protease nexin-1 contribute to pathological cardiac fibrosis via increasing collagen deposition","volume":"6","author":"Li","year":"2016","journal-title":"Scientific Rep."},{"key":"R114-20250802","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000369712","article-title":"Gene expression profile in the early stage of angiotensin ii-induced cardiac remodeling: a time series microarray study in a mouse model","volume":"35","author":"Dang","year":"2015","journal-title":"Cell Physiol Biochem."},{"key":"R115-20250802","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.ki.5001787","article-title":"Inhibition of prostasin-induced enac activities by pn-1 and regulation of pn-1 expression by tgf-beta1 and aldosterone","volume":"70","author":"Wakida","year":"2006","journal-title":"Kidney Int."},{"key":"R116-20250802","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"New Engl J Med."},{"key":"R117-20250802","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.1601896","article-title":"Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection","volume":"198","author":"Channappanavar","year":"2017","journal-title":"J Immunol."},{"key":"R118-20250802","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ddr.21688","article-title":"Androgen sensitivity gateway to covid-19 disease severity","volume":"81","author":"Wambier","year":"2020","journal-title":"Drug Dev Res."},{"key":"R119-20250802","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York city area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA."},{"key":"R120-20250802","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-13-1010","article-title":"The androgen-regulated protease tmprss2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis","volume":"4","author":"Lucas","year":"2014","journal-title":"Cancer Discov."},{"key":"R121-20250802","first-page":"1686","article-title":"Catalytic cleavage of the androgen-regulated tmprss2 protease results in its secretion by prostate and prostate cancer epithelia","volume":"61","author":"Afar","year":"2001","journal-title":"Cancer Res."},{"key":"R122-20250802","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","article-title":"Impact of sex and gender on covid-19 outcomes in europe","volume":"11","author":"Gebhard","year":"2020","journal-title":"Biol Sex Differences."},{"key":"R123-20250802","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1200\/JCO.2002.11.085","article-title":"Racial variation in cag repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status","volume":"20","author":"Bennett","year":"2002","journal-title":"J Clin Oncol."},{"key":"R124-20250802","first-page":"4180","article-title":"Prostate-localized and androgen-regulated expression of the membrane-bound serine protease tmprss2","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res."},{"key":"R125-20250802","doi-asserted-by":"crossref","first-page":"105074","DOI":"10.1016\/j.earlhumdev.2020.105074","article-title":"Understanding covid-19: digit ratio (2d:4d) and sex differences in national case fatality rates","volume":"146","author":"Manning","year":"2020","journal-title":"Early Hum Dev."},{"key":"R126-20250802","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2020.05.079","article-title":"Androgenetic alopecia present in the majority of hospitalized covid-19 patients\u2014the \u201cgabrin sign.\u201d","volume":"83","author":"Wambier","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"R127-20250802","article-title":"Androgen regulates sars-cov-2 receptor levels and is associated with severe covid-19 symptoms in men","author":"Ghazizadeh","year":"2020","journal-title":"bioRxiv."},{"key":"R128-20250802","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0016-5085(87)90428-8","article-title":"Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver","volume":"93","author":"Francavilla","year":"1987","journal-title":"Gastroenterology."},{"key":"R129-20250802","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1136\/hrt.2006.099523","article-title":"Management of patients with heart failure in clinical practice: differences between men and women","volume":"94","author":"Lenzen","year":"2008","journal-title":"Heart (British Cardiac Society)"},{"key":"R130-20250802","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/HYPERTENSIONAHA.120.15038","article-title":"Clinical applicability of monitoring antihypertensive drug levels in blood","volume":"76","author":"Peeters","year":"2020","journal-title":"Hypertension."},{"key":"R131-20250802","first-page":"8","article-title":"Pharmacological properties of a mineralocorticoid antagonist (sc-14266)","volume":"149","author":"Kagawa","year":"1964","journal-title":"Arch Internationales Pharmacodynamie Therapie."},{"key":"R132-20250802","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cca.2020.04.027","article-title":"Hyperinflammation and derangement of renin-angiotensin-aldosterone system in covid-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis","volume":"507","author":"Henry","year":"2020","journal-title":"Clinica Chim Acta Int J Clin Chem."},{"key":"R133-20250802","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"Covid-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"R134-20250802","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in covid-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"key":"R135-20250802","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1210\/jcem.87.2.7980","article-title":"Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans","volume":"87","author":"Sawathiparnich","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"R136-20250802","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1523-1755.2000.00160.x","article-title":"Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo","volume":"58","author":"Nakamura","year":"2000","journal-title":"Kidney Int."},{"key":"R137-20250802","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000066348","article-title":"Effect of spironolactone on impaired fibrinolysis of hypertensive patients","volume":"25","author":"Yalcin","year":"2002","journal-title":"Kidney Blood Press Res."},{"key":"R138-20250802","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/hr.2011.137","article-title":"Role of angiotensin ii in plasma pai-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome","volume":"34","author":"Fogari","year":"2011","journal-title":"Hypertens Res."},{"key":"R139-20250802","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/FJC.0b013e31805751d3","article-title":"Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension","volume":"50","author":"Liu","year":"2007","journal-title":"J Cardiovasc Pharmacol."},{"key":"R140-20250802","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1607-551X(09)70304-3","article-title":"Lercanidipine and losartan effects on blood pressure and fibrinolytic parameters","volume":"22","author":"Lin","year":"2006","journal-title":"Kaohsiung J Med Sci."},{"key":"R141-20250802","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/eurjhf\/hfp023","article-title":"Anti-inflammatory effects of eplerenone on viral myocarditis","volume":"11","author":"Xiao","year":"2009","journal-title":"Eur J Heart Fail."},{"key":"R142-20250802","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J Vet Intern Med."},{"key":"R143-20250802","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/ejhf.402","article-title":"Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on raas inhibitors","volume":"17","author":"Pitt","year":"2015","journal-title":"Eur J Heart Fail."},{"key":"R144-20250802","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/ejhf.300","article-title":"Maintenance of serum potassium with sodium zirconium cyclosilicate (zs-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial","volume":"17","author":"Anker","year":"2015","journal-title":"Eur J Heart Fail."},{"key":"R145-20250802","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (pathway-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet."},{"key":"R146-20250802","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s10157-015-1106-2","article-title":"Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial","volume":"19","author":"Kato","year":"2015","journal-title":"Clin Exp Nephrol."},{"key":"R147-20250802","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"New Engl J Med."}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FJC.0000000000000960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T22:06:54Z","timestamp":1754172414000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FJC.0000000000000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":145,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0000000000000960","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,4]]},"assertion":[{"value":"2020-09-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}